Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps

Abstract excerpt

Adeno-associated virus-based gene therapy for hemophilia has emerged as a revolutionary treatment option, offering potential correction of clotting factor deficiency through a single intravenous infusion of functional genes directed to hepatocytes. With 3 gene therapies recently approved, this approach shows promise in transforming the lives of individuals with hemophilia. However, the complexity of gene therapy...

Topics

Join the communities discussing this publication.

• CAR-T cell therapy research
• Hemophilia Treatment and Research
• Virus-based gene therapy research